Published in J Antimicrob Chemother on November 13, 2007
Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc Natl Acad Sci U S A (2010) 1.38
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol (2011) 1.21
Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants. Pediatr Infect Dis J (2013) 1.05
In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue. Cardiovasc Toxicol (2010) 0.89
In utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue. Cardiovasc Toxicol (2010) 0.86
Short communication: The relationship between mitochondrial dysfunction and insulin resistance in HIV-infected children receiving antiretroviral therapy. AIDS Res Hum Retroviruses (2013) 0.86
Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants. Pediatr Infect Dis J (2013) 0.82
Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1. Environ Mol Mutagen (2009) 0.81
The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain. Curr Neuropharmacol (2013) 0.81
WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication. Environ Mol Mutagen (2009) 0.81
Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy. Chem Res Toxicol (2008) 0.80
HIV-exposed infants: rethinking care for a lifelong condition. AIDS (2013) 0.80
The Immune System of HIV-Exposed Uninfected Infants. Front Immunol (2016) 0.79
Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy. Curr Opin Pediatr (2015) 0.78
Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth. AIDS Res Hum Retroviruses (2016) 0.78
Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo. AIDS Res Ther (2009) 0.75
Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra. AIDS Res Treat (2013) 0.75
Exposure of Allium cepa root cells to zidovudine or nevirapine induces cytogenotoxic changes. PLoS One (2014) 0.75
Mitochondrial toxicity and caspase activation in HIV pregnant women. J Cell Mol Med (2016) 0.75
Mitochondrial compromise in 3-year old patas monkeys exposed in utero to human-equivalent antiretroviral therapies. Environ Mol Mutagen (2016) 0.75
Quantification of mitochondrial toxicity in HIV-infected individuals by quantitative PCR compared to flow cytometry. Cytometry B Clin Cytom (2012) 0.75
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet (2006) 5.26
Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS (2008) 4.48
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS (2014) 2.67
Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J (2003) 1.90
Outcomes after viral load rebound on fi rst-line antiretroviraltreatment in children with HIV in the UK and Ireland:an observational cohort study. Lancet HIV (2015) 1.42
Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J (2006) 1.33
Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. AIDS Patient Care STDS (2009) 1.23
HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004. Pediatr Infect Dis J (2008) 1.13
Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13). Antivir Ther (2005) 1.12
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. AIDS (2010) 1.09
Pregnancy and HIV infection: A european consensus on management. AIDS (2002) 1.04
British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV Med (2014) 1.01
Nevirapine use in HIV-1-infected children. AIDS (2003) 0.99
Testing for HIV: concise guidance. Clin Med (2009) 0.98
Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection. AIDS (2014) 0.96
Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance. AIDS (2009) 0.94
Tenofovir use in human immunodeficiency virus-1-infected children in the United kingdom and Ireland. Pediatr Infect Dis J (2009) 0.93
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children. Pediatr Infect Dis J (2006) 0.91
When to start, what to start and other treatment controversies in pediatric HIV infection. Paediatr Drugs (2012) 0.89
Monitoring death and cancer in children born to HIV-infected women in England and Wales: use of HIV surveillance and national routine data. AIDS (2007) 0.87
Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland. AIDS (2014) 0.87
Fatal histiocytic proliferative disorders in paediatric HIV infection with cytomegalovirus end-organ disease. Br J Haematol (2009) 0.86
In utero exposure to antiretroviral therapy: feasibility of long-term follow-up. AIDS Care (2009) 0.85
Lopinavir/ritonavir population pharmacokinetics in neonates and infants. Br J Clin Pharmacol (2011) 0.84
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK. Antivir Ther (2011) 0.82
Children with human immunodeficiency virus admitted to a paediatric intensive care unit in the United Kingdom over a 10-year period. Intensive Care Med (2003) 0.80
Recurrent meningitis in association with common variable immune deficiency. Indian Pediatr (2004) 0.79
Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands. Pediatr Infect Dis J (2014) 0.78
Lopinavir dosing in HIV-infected children in the United Kingdom and Ireland. Pediatr Infect Dis J (2013) 0.77
Characteristics and outcomes of human parechovirus infection in infants (2008-2012). Eur J Pediatr (2015) 0.76
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial. Antivir Ther (2006) 0.76
Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy. Pediatr Infect Dis J (2014) 0.76
Intravenous iron and vertical HIV transmission: any connection? AIDS (2014) 0.75
Oral acyclovir suppression after neonatal herpes. N Engl J Med (2012) 0.75
False-positive HIV antibody results with ultrasensitive serological assays in uninfected infants born to mothers with HIV. AIDS (2007) 0.75
Hepatocellular Carcinoma in Perinatally Acquired HIV and HBV Co-Infection: A Case Report. Pediatr Infect Dis J (2017) 0.75
Current guidelines for the management of UK Infants born to HIV-1 infected mothers. Early Hum Dev (2004) 0.75
Preventing perinatal transmission of HIV--are we doing enough? Adv Exp Med Biol (2004) 0.75
Why are some babies still being infected with HIV in the UK? Adv Exp Med Biol (2010) 0.75
Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management. Pediatr Infect Dis J (2017) 0.75
Tenofovir-Associated Nephrotoxicity in Children with Perinatally-Acquired HIV Infection: A Single-Centre Cohort Study. Clin Drug Investig (2015) 0.75